Artivion Inc (AORT) Stock Analysis

Artivion Inc (AORT) is a publicly traded company in the HEALTHCARE sector. It trades at $20.43, carries a market capitalization of $1.04B, a price-to-earnings ratio of 85.44. This page summarizes the public market data, fundamentals, and frequently asked questions for AORT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

• Price: $20.43
• Market Cap: $1.04B
• P/E Ratio: 85.44
• EPS: $0.25
• 52-Week High: $48.25
• 52-Week Low: $19.16

Market Sentiment

Artivion Inc currently has a Bullish sentiment score of 0.43.

About Artivion Inc

Artivion Inc. is a pioneering leader in the field of implantable human tissues and advanced medical devices, dedicated to enhancing surgical outcomes and improving patient care worldwide. With a strong focus on tissue bioengineering and regenerative medicine, the company is at the forefront of innovation, delivering high-quality solutions that meet the evolving demands of the healthcare sector. Artivion's commitment to continuous improvement and excellence positions it as a key player in the ...

GNG Research Analysis

GNG Research scores Artivion Inc (AORT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for AORT.

Frequently Asked Questions

Does AORT pay dividends?

Artivion Inc (AORT) does not currently pay a regular dividend.

What is AORT's P/E ratio?

Artivion Inc has a price-to-earnings (P/E) ratio of 85.44.

What is AORT's market cap?

Artivion Inc (AORT) has a market capitalization of $1.04B with a current stock price of $20.43.